{"resourceType":"ValueSet","url":"https://fhir.kbv.de/ValueSet/KBV_VS_ERP_Medication_Category","version":"1.0.1","name":"KBV_VS_ERP_Medication_Category","status":"active","date":"2021-02-23","publisher":"Kassenärztliche Bundesvereinigung","compose":{"include":[{"system":"https://fhir.kbv.de/CodeSystem/KBV_CS_ERP_Medication_Category"}]},"expansion":{"identifier":"urn:uuid:6ff2b734-c712-4861-a6ee-f5c73a69ffc7","timestamp":"2022-10-11T14:01:13.4486263+02:00","total":3,"contains":[{"system":"https://fhir.kbv.de/CodeSystem/KBV_CS_ERP_Medication_Category","version":"1.0.1","code":"00","display":"Arzneimittel oder in die Arzneimittelversorgung nach § 31 SGB V einbezogenes Produkt"},{"system":"https://fhir.kbv.de/CodeSystem/KBV_CS_ERP_Medication_Category","version":"1.0.1","code":"01","display":"BtM"},{"system":"https://fhir.kbv.de/CodeSystem/KBV_CS_ERP_Medication_Category","version":"1.0.1","code":"02","display":"AMVV § 3a Abs. 1 (Thalidomid o. ä.)"}]}}